Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
CU

NASDAQ · CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Healthcare · Biotechnology

$1.69

Down-$0.21 (-11.05%)

Updated Oct 10, 2026, 6:39 PM

SID Score

5.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
10.3M
P/E ratio
-9.13
Dividend yield
0.00%
52-week range
$0.22 – $14.80
Volume
76.06K
Avg. volume
228.34K

Price performance · CUPR

CUPR price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

CUPR closed at $1.69 after 21 trading sessions, down 46.35% for the selected period.

Last close
$1.69
Period change
-46.35%
Period low
$1.60
Period high
$3.20
Daily close
View OHLC price history
CUPR OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$1.84$1.86$1.62$1.6976.06K
Oct 8, 2026$2.04$2.04$1.88$1.9015.1K
Oct 7, 2026$2.18$2.23$1.88$1.9985.29K
Oct 6, 2026$2.31$2.31$2.02$2.1742.39K
Oct 5, 2026$2.40$2.40$2.11$2.2543.43K
Oct 2, 2026$2.54$2.54$2.03$2.42331.87K
Oct 1, 2026$2.34$2.678$2.31$2.55145.12K
Sep 30, 2026$2.06$2.79$2.06$2.28907.77K
Sep 29, 2026$2.00$2.1494$2.00$2.0142.89K
Sep 28, 2026$1.97$2.09$1.9076$1.95135.42K
Sep 25, 2026$1.83$1.90$1.83$1.877.28K
Sep 24, 2026$1.83$1.905$1.81$1.90188.56K
Sep 23, 2026$1.99$1.99$1.88$1.8897.05K
Sep 22, 2026$1.89$2.00$1.86$1.99116.28K
Sep 21, 2026$1.79$1.89$1.78$1.8976.38K
Sep 18, 2026$1.70$1.79$1.6901$1.7996.21K
Sep 17, 2026$1.77$1.79$1.6563$1.73124.56K
Sep 16, 2026$1.60$1.79$1.445$1.601.28M
Sep 15, 2026$3.10$3.30$2.90$2.9390.83K
Sep 14, 2026$3.11$3.205$3.10$3.205.78K
Sep 11, 2026$3.00$3.23$2.9995$3.1524.06K

Latest CUPR news

The latest Smart Investors Daily articles mentioning CUPR.

Stock researchCompany · Overview

CUPR research

Overview

Company profile and research snapshot.

Company profile

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 2, 2026

Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group

Acquiring 100% of East Coast Podiatry (five clinics) and Orchard Clinic (two clinics) for approximately S$4.0 million (approximately US$3.1 million)Target Group generated FY2025 unaudited revenue of approximately S$9.1 million and unaudited normalized EBITDA of approximately S$1.2 million, based on unaudited management accountsSellers’ consideration shares subject to a lock-upAdds an established clinical platform directly aligned with Cuprina’s wound-care and collagen technologies SINGAPORE, Oct

Yahoo · Sep 29, 2026

Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter’s Over-Allotment Option in Connection with Public Offering

SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it closed the sale of an additional 648,373 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriter’s over-allotment option granted in connection with the Company’s public offe

Yahoo · Sep 18, 2026

Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering

SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced the closing of its previously announced public offering of an aggregate 4,322,489 Class A Ordinary Shares (“the Offering”) at a price of $1.15 per share (“the Offering Price”) to the public, for a total of approxim

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By